[METRIC]
A-A-53618A
20 March 1992
SUPERSEDING
A-A-0053618 (DM)
29 August 1988
COMMERCIAL ITEM DESCRIPTION
TERBUTALINE SULFATE TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-T-37836 which is cancelled.
Salient characteristics.
Shall be Terbutaline Sulfate Tablets, USP.
Shall be in accordance with the requirements of the USP.
All ingredients entering into the manufacture of the item shall be of pharmaceutical grade.
For Type I, tablets shall be considered by the FDA to be therapeutically equivalent to Terbutaline Sulfate Tablets, USP, as manufactured by Geigy Laboratories at the same dosage and administration schedule.
For Type II, tablets shall be considered by the FDA to be therapeutically equivalent to Terbutaline Sulfate Tablets, USP, as manufactured by Merrell Laboratories at the same dosage and administration schedule.
For Strength 1, shall contain 2.5 mg of Terbutaline Sulfate per tablet within the applicable assay limits for the tablets.
For Strength 2, shall contain 5.0 mg of Terbutaline Sulfate per tablet within the applicable assay limits for the tablets.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business